Mildly reduced alpha-1 antitrypsin levels are not associated with chronic airflow limitation, emphysema, or respiratory symptoms

Abstract Severe Alpha-1-antitrypsin (AAT) deficiency is a risk factor for chronic obstructive pulmonary disease and emphysema, but risks in mildly reduced AAT levels are unclear. We evaluated the association between mildly reduced serum-AAT levels and chronic airflow limitation (CAL), emphysema and respiratory symptoms, and risks in relation to smoking. We measured serum AAT in people aged 50–65 years in the population-based Swedish CArdioPulmonary bioImage Study (SCAPIS, n = 24,931). We carried out binary logistic regression models to assess pulmonary and cardiovascular outcomes associated with mildly reduced AAT levels. In total, 23,072 individuals had normal serum AAT concentration (≥ 0.86 g/L in men and ≥ 0.94 g/L in women), and 1,859 had mildly reduced AAT levels (0.61–0.85 g/L in men and 0.61–0.93 g/L in women). Mildly reduced AAT levels were not significantly associated with CAL, defined according to either GOLD criteria (CAL GOLD ) or the lower limit of normal (CAL LLN ), or with emphysema on computed tomography (CT): OR (95% CI) 1.01 (0.85–1.21) for CAL GOLD , 0.95 (0.80–1.13) for CAL LLN , and 0.94 (0.75–1.18) for emphysema. Mildly reduced AAT levels were associated with lower odds of DLCO < LLN (OR 0.71, 95% CI 0.57–0.87) and lower odds of respiratory symptoms (0.87 (0.78–0.97) compared with normal AAT levels. In this large population-based cohort, mildly reduced AAT levels were not independently associated with CAL or CT-defined emphysema. These findings suggest that mildly reduced AAT levels alone may not represent a major risk factor for airflow limitation or emphysema in the general population.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-11-16
DOI
https://doi.org/10.1038/s41598-026-79511-0
Primary Topic
Chronic Obstructive Pulmonary Disease (COPD) Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Mildly reduced alpha-1 antitrypsin levels are not associated with chronic airflow limitation, emphysema, or respiratory symptoms

Anna Moberg, Jonas Eriksson Ström, Eeva Piitulainen, Zoltán Szabó et al.
Scientific Reports
Chronic Obstructive Pulmonary Disease (COPD) Research
article

Mildly reduced alpha-1 antitrypsin levels are not associated with chronic airflow limitation, emphysema, or respiratory symptoms

Anna Moberg, Jonas Eriksson Ström, Eeva Piitulainen, Zoltán Szabó, Christer Janson, Suneela Zaigham, Adriana-Maria Hiller, Sköld Magnus, Anders Blomberg, John Brandberg, Eva Swahn, Magnus Ekström, Åse Johnsson, Annelie Behndig, Apostolos Bossios, Kjell Toren, Hanan Tanash, Maria Mannila, Anders Andersson, Ulf Nilsson, Eva Lindberg, Andrei Malinovschi, Ida Pesonen
article en

Abstract

Abstract Severe Alpha-1-antitrypsin (AAT) deficiency is a risk factor for chronic obstructive pulmonary disease and emphysema, but risks in mildly reduced AAT levels are unclear. We evaluated the association between mildly reduced serum-AAT levels and chronic airflow limitation (CAL), emphysema and respiratory symptoms, and risks in relation to smoking. We measured serum AAT in people aged 50–65 years in the population-based Swedish CArdioPulmonary bioImage Study (SCAPIS, n = 24,931). We carried out binary logistic regression models to assess pulmonary and cardiovascular outcomes associated with mildly reduced AAT levels. In total, 23,072 individuals had normal serum AAT concentration (≥ 0.86 g/L in men and ≥ 0.94 g/L in women), and 1,859 had mildly reduced AAT levels (0.61–0.85 g/L in men and 0.61–0.93 g/L in women). Mildly reduced AAT levels were not significantly associated with CAL, defined according to either GOLD criteria (CAL GOLD ) or the lower limit of normal (CAL LLN ), or with emphysema on computed tomography (CT): OR (95% CI) 1.01 (0.85–1.21) for CAL GOLD , 0.95 (0.80–1.13) for CAL LLN , and 0.94 (0.75–1.18) for emphysema. Mildly reduced AAT levels were associated with lower odds of DLCO < LLN (OR 0.71, 95% CI 0.57–0.87) and lower odds of respiratory symptoms (0.87 (0.78–0.97) compared with normal AAT levels. In this large population-based cohort, mildly reduced AAT levels were not independently associated with CAL or CT-defined emphysema. These findings suggest that mildly reduced AAT levels alone may not represent a major risk factor for airflow limitation or emphysema in the general population.

Scientific ReportsVol. 16(1)
Linköping University (SE), Uppsala University (SE), Karolinska University Hospital (SE), Lund University (SE), Sahlgrenska University Hospital (SE), Karolinska Institutet (SE), Region Västra Götaland (SE), Skåne University Hospital (SE), Region Skåne (SE), University of Gothenburg (SE), Umeå University (SE)
VINNOVA, Lunds Universitet, Linköpings Universitet, Karolinska Institutet, Knut och Alice Wallenbergs Stiftelse, Vetenskapsrådet, Umeå Universitet, Sahlgrenska Universitetssjukhuset, Göteborgs Universitet, Uppsala Universitet, Skånes universitetssjukhus
Good health and well-being
Chronic Obstructive Pulmonary Disease (COPD) Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon